Clarity Pharmaceuticals (ASX: CU6) Share Price

CU6

$2.15▲+4.37%

$801.9MRank #375 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$801.9M

Volume

2.1M

P/E Ratio

-5.54

EPS

-$0.1527

Dividend Yield

0.00%

52-Week High

$5.87

52-Week Low

$1.97

Beta

1.168

Clarity Pharmaceuticals (ASX: CU6) is an Australian-listed company in the Healthcare sector with a market capitalisation of $801.9M and the 375th-largest security on the ASX by market capitalisation. The CU6 share price is $2.15, up 4.37% today and down 7.26% over the past 12 months. Shares have traded between $1.97 and $5.87 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Clarity Pharmaceuticals reported revenue of $0 and a net loss of $55.5M.

Charts

$2.17

24H Range

$2.09

$2.20

52-Week Range

$1.97

$5.87

About Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd. is a clinical-stage company focused on developing innovative radiopharmaceutical products that serve as both diagnostic imaging tools and therapeutic agents for cancer treatment in both children and adults. Its primary offering is SARTATE, a targeted theranostic radiopharmaceutical specifically engineered for the diagnosis, staging, and treatment of cancers characterized by somatostatin receptor 2 expression. The company's developmental portfolio also includes SAR-Bombesin, a pan-cancer theranostic designed for tumors expressing the gastrin-releasing peptide receptor. Additionally, they are developing SAR-bisPSMA, a theranostic radiopharmaceutical specifically aimed at cancers exhibiting prostate-specific membrane antigen, facilitating their diagnosis, staging, and treatment. Clarity Pharmaceuticals further collaborates with the GU Research Network on the investigator-initiated X-Calibur trial, which investigates the use of 64Cu-SAR-bisPSMA in patients with known or suspected prostate cancer. Founded in 2010, the company is headquartered in Sydney, Australia.

IPO Date

25 Aug 2021

CEO

Michelle Parker

Employees

Website

claritypharmaceuticals.com

Key Financial Data

Revenue (Quarterly)	$0
Net Income (Quarterly)	$-55.5M
Total Assets	$255.7M
Total Debt	$0
Free Cash Flow	$-48.1M
Return on Equity	-23.85%
Profit Margin	—
Operating Margin	—

CU6 Frequently Asked Questions

What is the Clarity Pharmaceuticals (ASX: CU6) share price?

The CU6 share price is $2.15, up 4.37% for the day, based on the latest available ASX market data.

What is Clarity Pharmaceuticals's market capitalisation?

Clarity Pharmaceuticals has a market capitalisation of $801.9M, making it the 375th-largest security listed on the ASX.

Does Clarity Pharmaceuticals pay a dividend?

CU6 does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Clarity Pharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), CU6 reported revenue of $0 and a net loss of $55.5M.

How many CU6 shares are on issue?

Clarity Pharmaceuticals has approximately 372,971,230 shares on issue, based on its market capitalisation of $801.9M and current share price.

What sector is Clarity Pharmaceuticals in?

Clarity Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Clarity Pharmaceuticals list on the ASX?

Clarity Pharmaceuticals listed on the Australian Securities Exchange on 25 Aug 2021.

Latest News

Clarity Pharmaceuticals (CU6 ASX: CU6) Rises 9% as Traders Rotate Into Biotech Stocks

Kalkine21 May 2026

Clarity Pharmaceuticals (CU6 ASX: CU6) Rises 9% as Traders Rotate Into Biotech Stocks Kalkine

Clarity Pharmaceuticals Ltd's (ASX:CU6) market cap dropped AU$145m last week; individual investors who hold 48% were hit as were institutions

simplywall.st30 Jan 2026

Clarity Pharmaceuticals Ltd's (ASX:CU6) market cap dropped AU$145m last week; individual investors who hold 48% were hit as were institutions simplywall.st

Clarity Pharmaceuticals Ltd's (ASX:CU6) 9.7% loss last week hit both individual investors who own 48% as well as institutions

Yahoo Finance5 Feb 2026

Clarity Pharmaceuticals Ltd's (ASX:CU6) 9.7% loss last week hit both individual investors who own 48% as well as institutions Yahoo Finance

Insights: Clarity Pharmaceuticals Ltd (ASX:CU6)

smallcaps.com.au30 Oct 2025

Insights: Clarity Pharmaceuticals Ltd (ASX:CU6) smallcaps.com.au

Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares

The Motley Fool Australia18 Mar 2026

Buy, hold, sell: Clarity Pharmaceuticals, New Hope, and Orica shares The Motley Fool Australia

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
MSBMesoblast Limited	$2.52B	$1.95	0.00	0.00%	▼-1.02%
REGRegis Healthcare Limited	$1.80B	$5.95	39.00	1.17%	▼-1.16%
NEUNeuren Pharmaceuticals Limited	$1.69B	$13.39	38.25	0.00%	▲+0.60%
NANNanosonics Limited	$992.4M	$3.32	31.27	0.00%	–+0.00%
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
CUVClinuvel Pharmaceuticals Limited	$451.7M	$8.96	14.96	0.40%	▲+1.24%
OCCOrthocell Limited	$163.2M	$0.735	-12.98	0.00%	▼-1.34%
DXBDimerix Limited	$99.1M	$0.165	-5.17	0.00%	▼-2.94%

ETFs That Hold CU6

CU6 is held by 3 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.38% of its portfolio.

Fund	Portfolio Weight	Fund Size
ISOiShares S&P/ASX Small Ordinaries ETF	0.38%	$134.5M
VSOVanguard MSCI Australian Small Companies Index ETF	0.15%	$1.18B
VASVanguard Australian Shares Index ETF	0.04%	$26.10B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.11	$2.20	$2.09	$2.17	1.9M	▲+5.60%
11 June 2026	$2.06	$2.09	$2.02	$2.055	1.8M	▼-2.61%
10 June 2026	$2.10	$2.16	$2.08	$2.11	1.9M	▼-2.76%
9 June 2026	$2.18	$2.29	$2.11	$2.17	2.4M	▼-3.56%
8 June 2026	$2.33	$2.37	$2.25	$2.25	1.8M	▼-1.32%
5 June 2026	$2.33	$2.37	$2.25	$2.28	1.7M	▼-1.30%
4 June 2026	$2.31	$2.35	$2.25	$2.31	1.2M	–+0.00%
3 June 2026	$2.33	$2.33	$2.18	$2.31	3.1M	▼-1.70%
2 June 2026	$2.35	$2.42	$2.31	$2.35	2.2M	▼-0.21%
1 June 2026	$2.48	$2.57	$2.34	$2.355	2.5M	▼-4.85%
29 May 2026	$2.45	$2.54	$2.445	$2.475	2.1M	▲+1.85%
28 May 2026	$2.57	$2.59	$2.41	$2.43	2.4M	▼-6.90%
27 May 2026	$2.68	$2.71	$2.58	$2.61	1.7M	▼-1.69%
26 May 2026	$2.69	$2.69	$2.58	$2.655	1.9M	▼-2.03%
25 May 2026	$2.75	$2.79	$2.66	$2.71	1.9M	▼-0.73%
22 May 2026	$2.71	$2.83	$2.70	$2.73	878K	▲+1.11%
21 May 2026	$2.53	$2.76	$2.53	$2.70	1.9M	▲+7.57%
20 May 2026	$2.65	$2.66	$2.495	$2.51	2.2M	▼-5.64%
19 May 2026	$2.63	$2.68	$2.60	$2.66	1.9M	▲+2.31%
18 May 2026	$2.92	$2.965	$2.58	$2.60	3.7M	▼-10.96%
15 May 2026	$2.90	$3.00	$2.90	$2.92	1.2M	▲+1.57%
14 May 2026	$2.88	$2.93	$2.83	$2.875	1M	▲+0.88%
13 May 2026	$2.85	$2.89	$2.78	$2.85	1.5M	–+0.00%
12 May 2026	$2.94	$2.94	$2.81	$2.85	1.4M	▼-2.73%
11 May 2026	$2.89	$2.95	$2.75	$2.93	2.1M	▲+0.69%
8 May 2026	$2.89	$2.93	$2.85	$2.91	1.2M	▼-1.36%
7 May 2026	$2.93	$3.02	$2.89	$2.95	1.9M	▲+1.20%
6 May 2026	$3.04	$3.06	$2.90	$2.915	1.6M	▼-1.69%
5 May 2026	$3.11	$3.14	$2.95	$2.965	1.8M	▼-4.66%
4 May 2026	$2.90	$3.23	$2.85	$3.11	4.7M	▲+6.87%

About Clarity Pharmaceuticals Ltd

IPO Date

25 Aug 2021

CEO

Michelle Parker

Employees

Website

claritypharmaceuticals.com

CU6 Frequently Asked Questions

What is the Clarity Pharmaceuticals (ASX: CU6) share price?

The CU6 share price is $2.15, up 4.37% for the day, based on the latest available ASX market data.

What is Clarity Pharmaceuticals's market capitalisation?

Clarity Pharmaceuticals has a market capitalisation of $801.9M, making it the 375th-largest security listed on the ASX.

Does Clarity Pharmaceuticals pay a dividend?

CU6 does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Clarity Pharmaceuticals profitable?

In its most recent reported period (ending 31 Dec 2025), CU6 reported revenue of $0 and a net loss of $55.5M.

How many CU6 shares are on issue?

Clarity Pharmaceuticals has approximately 372,971,230 shares on issue, based on its market capitalisation of $801.9M and current share price.

What sector is Clarity Pharmaceuticals in?

Clarity Pharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Clarity Pharmaceuticals list on the ASX?

Clarity Pharmaceuticals listed on the Australian Securities Exchange on 25 Aug 2021.

Company

Market Cap

Price

P/E

Div Yield

1D Change

MSBMesoblast Limited

$2.52B

$1.95

0.00

0.00%

▼-1.02%

REGRegis Healthcare Limited

$1.80B

$5.95

39.00

1.17%

▼-1.16%

NEUNeuren Pharmaceuticals Limited

$1.69B

$13.39

38.25

0.00%

▲+0.60%

NANNanosonics Limited

$992.4M

$3.32

31.27

0.00%

–+0.00%

PYCPYC Therapeutics Limited

$711.3M

$1.22

-10.86

0.00%

▲+3.39%

CUVClinuvel Pharmaceuticals Limited

$451.7M

$8.96

14.96

0.40%

▲+1.24%

OCCOrthocell Limited

$163.2M

$0.735

-12.98

0.00%

▼-1.34%

DXBDimerix Limited

$99.1M

$0.165

-5.17

0.00%

▼-2.94%

ETFs That Hold CU6

CU6 is held by 3 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.38% of its portfolio.

Fund

Portfolio Weight

Fund Size

ISOiShares S&P/ASX Small Ordinaries ETF

0.38%

$134.5M

VSOVanguard MSCI Australian Small Companies Index ETF

0.15%

$1.18B

VASVanguard Australian Shares Index ETF

0.04%

$26.10B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$2.11	$2.20	$2.09	$2.17	1.9M	▲+5.60%
11 June 2026	$2.06	$2.09	$2.02	$2.055	1.8M	▼-2.61%
10 June 2026	$2.10	$2.16	$2.08	$2.11	1.9M	▼-2.76%
9 June 2026	$2.18	$2.29	$2.11	$2.17	2.4M	▼-3.56%
8 June 2026	$2.33	$2.37	$2.25	$2.25	1.8M	▼-1.32%
5 June 2026	$2.33	$2.37	$2.25	$2.28	1.7M	▼-1.30%
4 June 2026	$2.31	$2.35	$2.25	$2.31	1.2M	–+0.00%
3 June 2026	$2.33	$2.33	$2.18	$2.31	3.1M	▼-1.70%
2 June 2026	$2.35	$2.42	$2.31	$2.35	2.2M	▼-0.21%
1 June 2026	$2.48	$2.57	$2.34	$2.355	2.5M	▼-4.85%
29 May 2026	$2.45	$2.54	$2.445	$2.475	2.1M	▲+1.85%
28 May 2026	$2.57	$2.59	$2.41	$2.43	2.4M	▼-6.90%
27 May 2026	$2.68	$2.71	$2.58	$2.61	1.7M	▼-1.69%
26 May 2026	$2.69	$2.69	$2.58	$2.655	1.9M	▼-2.03%
25 May 2026	$2.75	$2.79	$2.66	$2.71	1.9M	▼-0.73%
22 May 2026	$2.71	$2.83	$2.70	$2.73	878K	▲+1.11%
21 May 2026	$2.53	$2.76	$2.53	$2.70	1.9M	▲+7.57%
20 May 2026	$2.65	$2.66	$2.495	$2.51	2.2M	▼-5.64%
19 May 2026	$2.63	$2.68	$2.60	$2.66	1.9M	▲+2.31%
18 May 2026	$2.92	$2.965	$2.58	$2.60	3.7M	▼-10.96%
15 May 2026	$2.90	$3.00	$2.90	$2.92	1.2M	▲+1.57%
14 May 2026	$2.88	$2.93	$2.83	$2.875	1M	▲+0.88%
13 May 2026	$2.85	$2.89	$2.78	$2.85	1.5M	–+0.00%
12 May 2026	$2.94	$2.94	$2.81	$2.85	1.4M	▼-2.73%
11 May 2026	$2.89	$2.95	$2.75	$2.93	2.1M	▲+0.69%
8 May 2026	$2.89	$2.93	$2.85	$2.91	1.2M	▼-1.36%
7 May 2026	$2.93	$3.02	$2.89	$2.95	1.9M	▲+1.20%
6 May 2026	$3.04	$3.06	$2.90	$2.915	1.6M	▼-1.69%
5 May 2026	$3.11	$3.14	$2.95	$2.965	1.8M	▼-4.66%
4 May 2026	$2.90	$3.23	$2.85	$3.11	4.7M	▲+6.87%